Prevalence and Disease-Specific Risk Factors for Lower Urinary Tract Symptoms in Systemic Sclerosis: An International Multicenter Study

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1218-1227. doi: 10.1002/acr.23454. Epub 2018 Jun 19.

Abstract

Objective: To determine the prevalence of lower urinary tract symptoms (LUTS) in systemic sclerosis (SSc), to find specific risk factors, and to assess their impact on quality of life (QoL).

Methods: In a multicenter study, 334 patients completed a self-administered questionnaire on LUTS and QoL. LUTS were classified into 3 main categories: storage, voiding, and post-micturition symptoms. Digestive symptoms burden was captured by a visual analog scale, divided into 5 equal categories. Multivariable logistic regressions were performed to test association between risk factors and LUTS categories. Linear regression adjusted the association between LUTS and QoL.

Results: LUTS were recorded in 311 SSc patients (96.0%) and classified as severe in 120 (38.0%). The storage category of LUTS was the most prevalent (91.9%), followed by voiding (72.2%) and then by post-micturition symptoms (49.8%). Risk factors identified in the multivariable models were higher than the median Health Assessment Questionnaire disability index (HAQ DI; odds ratio [OR] 4.2 [95% confidence interval (95% CI) 1.4-12.9]) in the storage category; higher than the median HAQ DI (OR 2.4 [95% CI 1.2-4.9]) for digestive symptoms burden (OR 1.9 [95% CI 1.3-2.7]) and synovitis (OR 4.8 [95% CI 1.0-22.6) in the voiding category; and higher for digestive symptoms burden (OR 1.2 [95% CI 1.0-1.5]) in the post-micturition category of symptoms. These factors also increased the odds of having further severe symptoms. QoL was affected by the 3 categories of LUTS and decreased progressively with increasing frequency of symptoms.

Conclusion: Self-reported LUTS are among the most frequent symptoms in SSc and are associated with digestive symptoms. SSc patients with LUTS have lower QoL.

Trial registration: ClinicalTrials.gov NCT01971294.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Age Distribution
  • Aged
  • Comorbidity
  • Female
  • France
  • Humans
  • Internationality
  • Italy
  • Lower Urinary Tract Symptoms / diagnosis*
  • Lower Urinary Tract Symptoms / epidemiology*
  • Male
  • Middle Aged
  • Prevalence
  • Prognosis
  • Quality of Life*
  • Risk Factors
  • Scleroderma, Systemic / diagnosis*
  • Scleroderma, Systemic / epidemiology*
  • Scleroderma, Systemic / therapy
  • Severity of Illness Index
  • Sex Distribution
  • Surveys and Questionnaires*
  • Switzerland

Associated data

  • ClinicalTrials.gov/NCT01971294